- American City Business Journals•6 months ago
The U.S. Securities and Exchange Commission has revoked the securities of two once-promising Tampa Bay biopharmaceutical companies. The companies, Accentia Biopharmaceuticals Inc. in Tampa and Biostem U.S. Corp. in Clearwater, have not filed quarterly reports with the SEC for more than three years, and failed to respond to delinquency letters sent to them, according to an Oct. 16 order instituting administrative proceedings against the firms. Neither company answered the allegations, and the SEC made its decision to revoke their securities official in a decision issued on Jan. 15.
We're sorry this is all we were able to find about this topic.
ACCENTIA BIOPHARMACEOther OTC
|Day's Range||0.00 - 0.00|
|Avg Vol (3m)||N/A|
As of 3:27 PM EST. Other OTC Delayed Price. Market open.